血清与含抗凝剂血浆对基于流感病毒神经氨酸酶的血清学检测的影响
研究比较了配对血清与不同类型血浆中流感A型和B型病毒神经氨酸酶(NA)抗体滴度,使用酶联凝集素试验(ELLA)和酶联免疫吸附试验(ELISA)。结果显示血清与血浆滴度相关性良好但一致性差,血浆滴度常低于血清,且季节性流感疫苗接种后的NA特异性应答在血清与血浆间存在差异。数据提示应统一使用血清以标准化NA血清学检测。
要点
- 血清与不同类型血浆的NA抗体滴度相关性好但一致性常较差。
- 血浆样本的NA抗体滴度常低于配对血清样本。
- 季节性流感疫苗接种后的NA特异性应答在血清与血浆间存在差异。
核心结论
- 数据提示血清与血浆中NA特异性抗体测定存在差异,应考虑统一使用血清以标准化基于NA的血清学检测。
研究设计与样本
- 比较配对血清与不同类型血浆中针对流感A型和B型病毒NA的抗体滴度,使用ELLA和ELISA进行检测。
主要发现
- 血清与不同类型血浆测定的滴度之间相关性良好。
- 血清与不同类型血浆在ELLA和ELISA中的名义滴度值一致性可变且常较差,血浆样本常导致比血清样本更低的滴度。
- 在血清与血浆中评估的季节性流感疫苗接种后NA特异性应答存在差异。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The influenza virus neuraminidase (NA) is a promising target for next-generation influenza vaccines but standardised protocols for NA-based serological assays are lacking. Previous studies have demonstrated discordant results from haemagglutination inhibition and live virus microneutralization assays when comparing matched serum and plasma samples. It is therefore important to consider the choice of serum or plasma samples in assays measuring influenza virus NA-specific antibodies. Here, we compared antibody titres against influenza A and B virus NAs in matched serum and different types of plasma using an enzyme-linked lectin assay (ELLA) and an enzyme-linked immunosorbent assay (ELISA). We observed good correlations between titres determined in serum and different types of plasma. However, there was variable and often poor agreement in the nominal titre values obtained from serum and different kinds of plasma in both ELLA and ELISA, with plasma samples often resulting in lower titres compared to serum samples. We also found differences in NA-specific responses to seasonal influenza vaccination assessed in serum versus plasma. Overall, our data suggest discrepancies between NA-specific antibody measurements in serum and plasma. Therefore, the consistent use of serum should be considered in standardising NA-based serological assays.
引用
- Do THT, Kent SJ, Wheatley AK, et al. Impact of serum versus anticoagulant-containing plasma on influenza virus neuraminidase-based serological assays. Vaccine. 2025. PMID: 41223691. doi:10.1016/j.vaccine.2025.127956
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。